Synthesis and in vitro Metabolic Stability of Sterically Shielded Antimycobacterial Phenylalanine Amides
Open Access
- 29 February 2024
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 19 (6) , e202300593
Abstract
Nα‐aroyl‐N‐aryl‐phenylalanine amides (AAPs) are RNA polymerase inhibitors with activity against Mycobacterium tuberculosis and non‐tuberculous mycobacteria. We observed that AAPs rapidly degrade in microsomal suspensions, suggesting that avoiding hepatic metabolism is critical for their effectiveness in vivo. As both amide bonds are potential metabolic weak points of the molecule, we synthesized 16 novel AAP analogs in which the amide bonds are shielded by methyl or fluoro substituents in close proximity. Some derivatives show improved microsomal stability, while being plasma‐stable and non‐cytotoxic. In parallel with the metabolic stability studies, the antimycobacterial activity of the AAPs against Mycobacterium tuberculosis, Mycobacterium abscessus, Mycobacterium avium and Mycobacterium intracellulare was determined. The stability data are discussed in relation to the antimycobacterial activity of the panel of compounds and reveal that the concept of steric shielding of the anilide groups by a fluoro substituent has the potential to improve the stability and bioavailability of AAPs.Keywords
This publication has 57 references indexed in Scilit:
- Risk Factors for Nontuberculous Mycobacterial Pulmonary DiseaseChest, 2023
- Redesign of Rifamycin Antibiotics to Overcome ADP‐Ribosylation‐Mediated ResistanceAngewandte Chemie, 2022
- Racemization-free synthesis of Nα-2-thiophenoyl-phenylalanine-2-morpholinoanilide enantiomers and their antimycobacterial activityAmino Acids, 2021
- Multi-Drug Resistant and Extensively-Drug Resistant TuberculosisIndian Journal of Pediatrics, 2020
- Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosisJournal of Infection and Public Health, 2018
- 1,3,5-triazaspiro[5.5]undeca-2,4-dienes as selective Mycobacterium tuberculosis dihydrofolate reductase inhibitors with potent whole cell activityEuropean Journal of Medicinal Chemistry, 2018
- Structural Basis of Mycobacterium tuberculosis Transcription and Transcription InhibitionMolecular Cell, 2017
- Fueling Open‐Source Drug Discovery: 177 Small‐Molecule Leads against TuberculosisChemMedChem, 2013
- Species Difference of Esterase Expression and Hydrolase Activity in PlasmaJournal of Pharmaceutical Sciences, 2012
- SC-29333: A potent inhibitor of canine gastric secretionDigestive Diseases and Sciences, 1976